The crosstalk between STAT3 and microRNA in cardiac diseases and protection

Lan Wu1,2, Zhizheng Li3, Yanfei Li1,3

  • 1Affiliated Zhoupu Hospital and Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.

Insights

Signal transducer and activator of transcription 3 (STAT3) influences cardiac disease and protection by regulating genes and signaling pathways. STAT3 also interacts with microRNAs (miRNAs), affecting gene expression in the heart.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Gene Regulation

Background:

  • Signal transducer and activator of transcription 3 (STAT3) is a key transcription factor and signaling molecule involved in cardiac function.
  • STAT3 modulates the expression of genes related to oxidative stress, apoptosis, inflammation, and fibrosis in the heart.
  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression post-transcriptionally.

Purpose of the Study:

  • To review the intricate relationship between STAT3 and miRNAs in the context of cardiac disease and protection.
  • To elucidate how STAT3 regulates individual miRNAs and how miRNAs modulate STAT3 activity in cardiomyocytes.
  • To understand the implications of these interactions on cardiac pathophysiology and therapeutic strategies.

Main Methods:

  • Literature review and synthesis of existing research on STAT3 and miRNA interactions in cardiovascular contexts.
  • Analysis of studies detailing STAT3's role as both a regulator and target of miRNAs.
  • Examination of experimental evidence demonstrating altered mRNA expression profiles in cardiomyocytes due to STAT3-miRNA crosstalk.

Main Results:

  • STAT3 acts as a transcription factor, upregulating protective genes (anti-oxidative, anti-apoptotic) and suppressing detrimental genes (anti-inflammatory, anti-fibrotic) in cardiac conditions.
  • STAT3 is intricately linked with miRNAs, functioning as both a target and a modulator of miRNA expression.
  • These interactions lead to significant modifications in mRNA expression within cardiomyocytes, impacting cardiac disease progression and protection.

Conclusions:

  • The interplay between STAT3 and miRNAs represents a critical regulatory axis in cardiac disease and protection.
  • Understanding this crosstalk is essential for deciphering complex cardiac signaling networks.
  • Targeting the STAT3-miRNA axis may offer novel therapeutic avenues for cardiovascular diseases.